People Daily | by George Kebaso
The cost per dose of the new Covid-19 vaccine set to be produced by a German-based firm could be higher than the initial Sh300 projected for developing countries including Kenya, an expert has cautioned.
Prof Omu Anzala, a virologist, reacting to the announcement by Pfizer Inc that it was on the verge of producing a vaccine that could be 90 per cent effective against coronavirus, said it would be a long journey before it reaches patients…
